Leukemia

Leukemia

白血病

  • 1区 中科院分区
  • Q1 JCR分区

期刊简介

《Leukemia》是由Springer Nature出版社于1997年创办的英文国际期刊(ISSN: 0887-6924,E-ISSN: 1476-5551),该期刊长期致力于血液学领域的创新研究,主要研究方向为医学-血液学。作为SCIE收录期刊(JCR分区 Q1,中科院 1区),本刊采用OA未开放获取模式(OA占比0.4573...%),以发表血液学领域等方向的原创性研究为核心(研究类文章占比95.16%%)。凭借严格的同行评审与高效编辑流程,期刊年载文量精选控制在186篇,确保学术质量与前沿性。成果覆盖Web of Science、Scopus等国际权威数据库,为学者提供推动医学领域高水平交流平台。

投稿咨询

投稿提示

Leukemia审稿周期约为 一般,3-6周 。该刊近年未被列入国际预警名单,年发文量约186篇,录用竞争适中,主题需确保紧密契合医学前沿。投稿策略提示:避开学术会议旺季投稿以缩短周期,语言建议专业润色提升可读性。

  • 医学 大类学科
  • English 出版语言
  • 是否预警
  • SCIE 期刊收录
  • 186 发文量

中科院分区

中科院 SCI 期刊分区 2023年12月升级版

Top期刊 综述期刊 大类学科 小类学科
医学
1区
HEMATOLOGY 血液学 ONCOLOGY 肿瘤学
1区 1区

中科院 SCI 期刊分区 2022年12月升级版

Top期刊 综述期刊 大类学科 小类学科
医学
1区
HEMATOLOGY 血液学 ONCOLOGY 肿瘤学
1区 1区

JCR分区

按JIF指标学科分区 收录子集 分区 排名 百分位
学科:HEMATOLOGY SCIE Q1 6 / 97

94.3%

学科:ONCOLOGY SCIE Q1 19 / 322

94.3%

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:HEMATOLOGY SCIE Q1 7 / 97

93.3%

学科:ONCOLOGY SCIE Q1 25 / 322

92.39%

CiteScore

CiteScore SJR SNIP CiteScore 排名
CiteScore:18.1 SJR:3.662 SNIP:2.441
学科类别 分区 排名 百分位
大类:Medicine 小类:Hematology Q1 7 / 137

95%

大类:Medicine 小类:Oncology Q1 24 / 404

94%

大类:Medicine 小类:Cancer Research Q1 17 / 230

92%

期刊发文

  • Molecular landscape of immune pressure and escape in aplastic anemia

    Author: Pagliuca, Simona; Gurnari, Carmelo; Hercus, Colin; Hergalant, Sebastien; Nadarajah, Niroshan; Wahida, Adam; Terkawi, Laila; Mori, Minako; Zhou, Weiyin; Visconte, Valeria; Spellman, Stephen; Gadalla, Shahinaz M.; Zhu, Caiying; Zhu, Ping; Haferlach, Torsten; Maciejewski, Jaroslaw P.

    Journal: LEUKEMIA. 2023; Vol. 37, Issue 1, pp. 202-211. DOI: 10.1038/s41375-022-01723-w

  • Loss of bisecting GlcNAcylation on MCAM of bone marrow stoma determined pro-tumoral niche in MDS/AML

    Author: Feng, Jingjing; Wang, Yi; Li, Bingxin; Yu, Xinwen; Lei, Lei; Wu, Jinpeng; Zhang, Xin; Chen, Qiushi; Zhou, Yue; Gou, Junjie; Li, Hongjiao; Tan, Zengqi; Dai, Zhijun; Li, Xiang; Guan, Feng

    Journal: LEUKEMIA. 2023; Vol. 37, Issue 1, pp. 113-121. DOI: 10.1038/s41375-022-01748-1

  • Inhibition of USP1 reverses the chemotherapy resistance through destabilization of MAX in the relapsed/refractory B-cell lymphoma

    Author: Li, Xi-Ya; Wu, Ji-Chuan; Liu, Ping; Li, Zi-Juan; Wang, Yong; Chen, Bing-Yi; Hu, Cheng-Long; Fei, Ming-Yue; Yu, Peng-Cheng; Jiang, Yi-Lun; Xu, Chun-Hui; Chang, Bin-He; Chen, Xin-Chi; Zong, Li-Juan; Zhang, Jia-Ying; Fang, Ying; Sun, Xiao-Jian; Xue, Kai; Wang, Li; Chen, Shu-Bei; Jiang, Shi-Yu; Gui, Ai-ling; Yang, Ling; Gu, Juan J.; Yu, Bao-Hua; Zhang, Qun-ling; Wang, Lan

    Journal: LEUKEMIA. 2023; Vol. 37, Issue 1, pp. 164-177. DOI: 10.1038/s41375-022-01747-2

  • Targeting cell cycle and apoptosis to overcome chemotherapy resistance in acute myeloid leukemia

    Author: Ling, Victoria Y.; Straube, Jasmin; Godfrey, William; Haldar, Rohit; Janardhanan, Yashaswini; Cooper, Leanne; Bruedigam, Claudia; Cooper, Emily; Shirazi, Paniz Tavakoli; Jacquelin, Sebastien; Tey, Siok-Keen; Baell, Jonathan; Huang, Fei; Jin, Jianwen; Zhao, Yichao; Bullinger, Lars; Bywater, Megan J.; Lane, Steven W.

    Journal: LEUKEMIA. 2023; Vol. 37, Issue 1, pp. 143-153. DOI: 10.1038/s41375-022-01755-2

  • Dual inhibition of CHK1/FLT3 enhances cytotoxicity and overcomes adaptive and acquired resistance in FLT3-ITD acute myeloid leukemia

    Author: Jiang, Kailong; Li, Xuemei; Wang, Chang; Hu, Xiaobei; Wang, Peipei; Tong, Lexian; Tu, Yutong; Chen, Beijing; Jin, Tingting; Wang, Tao; Wang, Hanlin; Han, Yubing; Gui, Renzhao; Yang, Jianmin; Liu, Tao; Li, Jia; Zhou, Yubo

    Journal: LEUKEMIA. 2023; Vol. 37, Issue 3, pp. 539-549. DOI: 10.1038/s41375-022-01795-8

  • Microenvironmental CXCL12 deletion enhances Flt3-ITD acute myeloid leukemia stem cell response to therapy by reducing p38 MAPK signaling

    Author: Anderson, Nicholas R.; Sheth, Vipul; Li, Hui; Harris, Mason W.; Qiu, Shaowei; Crossman, David K.; Kumar, Harish; Agarwal, Puneet; Nagasawa, Takashi; Paterson, Andrew J.; Welner, Robert S.; Bhatia, Ravi

    Journal: LEUKEMIA. 2023; Vol. 37, Issue 3, pp. 560-570. DOI: 10.1038/s41375-022-01798-5

  • HIF1 alpha-mediated transactivation of WTAP promotes AML cell proliferation via m(6)A-dependent stabilization of KDM4B mRNA

    Author: Shao, Yang-Liu; Li, Yu-Qing; Li, Meng-Yue; Wang, Li-Li; Zhou, Hui-Sheng; Liu, Dai-Hong; Yu, Li; Lin, Ji; Gao, Xiao-Ning

    Journal: LEUKEMIA. 2023; Vol. , Issue , pp. -. DOI: 10.1038/s41375-023-01904-1

  • Targeting DNA polymerase beta elicits synthetic lethality with mismatch repair deficiency in acute lymphoblastic leukemia

    Author: Teng, Ji-Yuan; Yang, Ding-Peng; Tang, Chao; Fang, Hou-Shun; Sun, Hui-Ying; Xiang, Yue-Ning; Li, Xiao-Meng; Yang, Fan; Xia, Rui-Xue; Fan, Fu; Liu, Jingjing; Yu, Jiyang; Hu, Jin-Chuan; Li, Ben-Shang; Li, Hui; Meng, Fei-Long; Duan, Cai-Wen; Zhou, Bin-Bing S.

    Journal: LEUKEMIA. 2023; Vol. , Issue , pp. -. DOI: 10.1038/s41375-023-01902-3